BioLife Solutions Inc. vs. Electromed, Inc.
Electromed, Inc. (ELMD) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| BLFS | ELMD | |
|---|---|---|
| Market Cap | $1.88 billion | $233.25 million |
| Revenue (TTM) | $102.82 million | $73.78 million |
| Net Income (TTM) | $57.98 million | $11.30 million |
BLFS leads on 3 of 3 size & scale factors.
Valuation
| BLFS | ELMD | |
|---|---|---|
| P/E Ratio | 32.90 | 21.45 |
| Price / Book | 4.48 | 4.32 |
| Price / Sales | 18.31 | 3.16 |
ELMD leads on 3 of 3 valuation factors.
Profitability
| BLFS | ELMD | |
|---|---|---|
| Net Margin | 56.39% | 15.32% |
| Return on Equity | 13.80% | 20.94% |
BLFS and ELMD split the profitability factors evenly.
Risk & Sentiment
| BLFS | ELMD | |
|---|---|---|
| Short Interest | 1.61% | 0.81% |
ELMD leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLFS overview, BLFS financials, ELMD overview, ELMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.